DarioHealth Corp.
$7.46
▲
3.7%
2026-04-21 06:29:00
www.dariohealth.com
NCM: DRIO
Explore DarioHealth Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$54.46 M
Current Price
$7.46
52W High / Low
$17.74 / $5.93
Stock P/E
—
Book Value
$9.84
Dividend Yield
—
ROCE
-36.38%
ROE
-59.62%
Face Value
—
EPS
$-10.12
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
160
Beta
1.28
Debt / Equity
46.74
Current Ratio
3.76
Quick Ratio
3.3
Forward P/E
-16.67
Price / Sales
2.37
Enterprise Value
$58.66 M
EV / EBITDA
-1.75
EV / Revenue
2.62
Rating
None
Target Price
$18.8
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Carlsmed, Inc. | $10.94 | — | $293.52 M | — | -26.39% | -47.62% | $17.19 / $8.5 | $3.72 |
| 2. | HeartBeam, Inc. | $0.92 | — | $37.8 M | — | -812.1% | -9.87% | $4 / $0.54 | $0.07 |
| 3. | Talkspace, Inc. | $5.18 | 111.06 | $865.45 M | — | 2.68% | 6.65% | $5.2 / $2.22 | $0.7 |
| 4. | Health Catalyst, Inc. | $1.26 | — | $92.72 M | — | -10.35% | -58.26% | $5.06 / $0.96 | $3.41 |
| 5. | SOPHiA GENETICS SA | $5.19 | — | $371.96 M | — | -63.03% | -1.1% | $5.7 / $2.58 | $0.69 |
| 6. | So-Young International Inc. | $2.9 | — | $283.61 M | 0% | -4.01% | -13.61% | $6.28 / $0.74 | $2.25 |
| 7. | Mangoceuticals, Inc. | $0.51 | — | $7.43 M | — | -62.34% | -1.42% | $2.88 / $0.16 | $1.13 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 5.23 M | 5.01 M | 5.37 M | 6.75 M | 7.6 M | — |
| Operating Profit | -8.56 M | -9.48 M | -9.2 M | -9.41 M | -11.67 M | — |
| Net Profit | -9.03 M | -10.47 M | -12.99 M | -9.23 M | -9.63 M | — |
| EPS in Rs | -1.24 | -1.43 | -1.78 | -1.26 | -1.32 | -4.91 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 22.36 M | 27.04 M | 20.35 M | 27.66 M |
| Operating Profit | -36.66 M | -57.74 M | -56.19 M | -56.81 M |
| Net Profit | -41.71 M | -42.75 M | -59.43 M | -62.19 M |
| EPS in Rs | -5.71 | -5.86 | -8.14 | -8.52 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 110.08 M | 118.88 M | 96.39 M | 119.19 M |
| Total Liabilities | 42.15 M | 46.87 M | 38.24 M | 39.19 M |
| Equity | 67.92 M | 72.02 M | 58.14 M | 80 M |
| Current Assets | 35.07 M | 40.53 M | 47.33 M | 65.52 M |
| Current Liabilities | 9.32 M | 16.64 M | 12.49 M | 19.35 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -25.94 M | -38.56 M | -30.38 M | -47.84 M |
| Investing CF | -4.34 M | -8.93 M | -0.55 M | -0.57 M |
| Financing CF | 24.31 M | 38.53 M | 18.25 M | 61.94 M |
| Free CF | -26.08 M | -38.7 M | -30.96 M | -48.42 M |
| Capex | -0.14 M | -0.14 M | -0.58 M | -0.57 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 32.86% | -26.41% | — | — |
| Earnings Growth % | 28.07% | 4.45% | — | — |
| Profit Margin % | -158.09% | -292% | -224.88% | — |
| Operating Margin % | -213.55% | -276.09% | -205.42% | — |
| Gross Margin % | 49.06% | 29.4% | 34.91% | — |
| EBITDA Margin % | -137.47% | -251.59% | -201.03% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-08-28 | 1:0.05 |